Antibiotic resistance rising in India, ICMR report finds
Common bacteria like E. coli and Klebsiella pneumoniae are showing low effectiveness against standard antibiotics in both large and secondary-care hospitals.
Common bacteria responsible for routine and serious infections are no longer responding to antibiotics used for years in India. The Indian Council of Medical Research (ICMR) Antimicrobial Resistance Surveillance and Research Network (AMRSN) 2025 report found low effectiveness of several drugs against E. coli and Klebsiella pneumoniae, which cause pneumonia, urinary tract, and bloodstream infections.
In large hospitals, E. coli accounted for 24.4 per cent of samples, followed by Klebsiella pneumoniae at 16.9 per cent, Pseudomonas aeruginosa at 12.2 per cent, and Acinetobacter baumannii at 9.5 per cent.
Resistance to third-generation cephalosporins is very high in secondary-care hospitals, while carbapenem resistance remains a major issue in larger, specialised facilities. Specifically, 91.1 per cent of tested A. baumannii samples showed resistance to carbapenems. Klebsiella pneumoniae was identified as the primary bacterium found in newborns with bloodstream infections.
E. coli showed low response rates to common antibiotics, with only 18.4 per cent responding to cefotaxime, 24.7 per cent to ceftazidime, and 9 per cent to ciprofloxacin. For Klebsiella pneumoniae, only 36.5 to 40.4 per cent of samples responded to carbapenems.
Dr. Kamini Walia, a scientist and head of the Descriptive Research Division at ICMR, stated that routine infections are already becoming significantly harder to treat. The misuse of antibiotics for viral infections or illnesses that do not require them is a main driver of this resistance.
To address the threat, the ICMR suggests that district and smaller hospitals establish antimicrobial stewardship and infection control committees. Improving infection prevention through handwashing, equipment cleaning, and instrument sterilisation is also necessary.
Key facts
- E. coli and Klebsiella pneumoniae are showing low effectiveness against many commonly used antibiotics.
- The ICMR 2025 report included data from 34 secondary-care hospitals for the first time.
- 91.1 per cent of tested A. baumannii samples were resistant to carbapenems.
Three perspectives
Neutral
The ICMR 2025 report shows varying levels of antibiotic resistance across different types of bacteria and hospital settings in India.
Positive
The inclusion of 34 secondary-care hospitals in the latest report provides a wider understanding of resistance patterns beyond large specialised facilities.
Negative
Drug-resistant bacteria are making routine infections harder to treat and forcing doctors to use expensive last-resort antibiotics with higher side-effect risks.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.